NEWS
Apr 09, 2026

SSRP Institute Welcomes StemWave as New Trusted Partner

PARTNER ANNOUNCEMENT

WILLOUGHBY, Ohio, [April 9, 2026] — The SSRP Institute announces that StemWave has joined its Trusted Partner Network following nomination and completion of the SSRP’s internal review process.

StemWave provides an FDA-listed, non-invasive acoustic wave therapy platform used in musculoskeletal care. The technology delivers focused mechanical energy to targeted tissues, supporting improved circulation, modulation of inflammatory signaling, and activation of the body’s natural repair processes. It is commonly applied across soft tissue and joint-related conditions involving the shoulder, spine, hip, knee, ankle, foot, and associated tendons and ligaments.

“StemWave's focused shockwave therapy has delivered exceptional clinical outcomes in my regenerative practice, with its ability to enhance tissue regeneration and activate natural healing. Their evidence-based approach and commitment to clinical excellence make them an ideal partner for the SSRP community,” said Dr. Gerald Morris, SSRP nominating Member. 

From a cellular perspective, acoustic wave therapy influences microvascular perfusion, mechanotransduction pathways, and tissue remodeling. Research in shockwave therapy demonstrates improved blood flow and inflammation modulation, aligning with treatment goals for chronic pain and soft tissue dysfunction. Treatments are brief, non-pharmacologic, and designed to complement comprehensive regenerative care plans.

"Rooted in science and performance, SSRP is spearheading a cultural shift in healthcare,” says Jake Ellis of StemWave. “The values and transparency of this community made it an obvious partnership for us at StemWave! We’re thrilled and grateful to amplify SSRP’s mission with practical, evidence-driven tools, further fueling the highest standards in clinician support and patient outcomes." 

Through these partnerships, the SSRP aims to support Members by connecting them with vetted resources that complement training, protocol development, and implementation in practice.

For more information and to view the StemWave Partner Page, visit:
SSRP StemWave Partner Page


About the SSRP Institute

The SSRP Institute is an education-focused organization dedicated to advancing cellular medicine through evidence-based training, professional collaboration, and clinically relevant research. SSRP supports providers worldwide through certifications, events, and ongoing educational programming designed to improve patient outcomes and elevate the standard of care.

The SSRP Trusted Partner Network is invitation-only and based on real-world clinical relevance, thoughtful nomination, and alignment with SSRP’s educational principles. Partners are integrated through a structured process designed to foster collaboration, support clinician education, and strengthen the implementation of cellular medicine practices.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
Uncategorized Apr 29, 2026
New ACC and AHA Cholesterol Management Guidelines
BREAKING NEWS APRIL 29, 2026 – The American College of Cardiology (ACC) and American Heart Association (AHA) have updated their cholesterol management guidelines, advocating for earlier and more aggressive intervention based on the understanding that cumulative lifetime exposure to high LDL-C drives atherosclerotic cardiovascular disease (ASCVD) risk. The guidelines aim to standardize care for dyslipidemia […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 27, 2026
Ep. 085 - Peptide Pharmacokinetics
Preview Only
Dissecting Protocols – Episode 085

Peptide Pharmacokinetics

Dissecting Protocols, Dr. Seeds breaks down the reasoning behind SubQ vs. IM peptide administration. From pharmacokinetic considerations to the growing misuse of combining peptides with oil-based medications in the same syringe, this discussion helps clarify proper application and safety considerations.

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
William Seeds, MD Apr 21, 2026
A Review of Circadian Processes and Evidence-Based Interventions to Improve Sleep
Introduction In March of this year, I did a Rabbit Hole (Episode 079) in which I discussed a number of trends marketed to the wider public promising sleep improvement. As you know, a huge swath of the population suffers from sleep disturbance. According to the NIH, approximately 30% to 40% of US adults report sleep […]
READ ARTICLE
VIDEO
Cellular Medicine Mondays
Apr 20, 2026
Ep. 084 - The Cellular Impact of UVA vs. UVB Light (Part 2)
Preview Only
Rabbit Holes – Episode 084

The Cellular Impact of UVA vs. UVB Light (Part 2)

Dr. Seeds continues this Rabbit Hole on UVA vs. UVB light in Part 2, covering oxidative stress, skin aging, vitamin D synthesis, and the risks of tanning beds. A helpful look at why not all UV exposure works the same, why that distinction matters, and how it shapes both skin health and cellular function

Catch Part 1 (Rabbit Holes – Ep. 081) HERE

Preview Only — Become a member for full access
SSRP Institute Apr 15, 2026
FDA Announces Change in Status of 12 Peptides
BREAKING NEWS APRIL 15, 2026 – In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500. Originally nominated for Category 2 (Bulk Substances that […]
READ NEWS
VIDEO
Cellular Medicine Mondays
Apr 13, 2026
Ep. 083 - Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients
Preview Only
Journal Club – Episode 083

Safety of Low-Dose Oral Minoxidil for Hair Loss: A Multicenter Study of 1404 Patients

Dr. Seeds discusses this article on low dose minoxidil for hair loss and shares why a lower, slower dosing approach may lead to better outcomes. He also reviews key safety considerations, side effects, and practical dosing insights for both men and women. (Article Link)

Preview Only — Become a member for full access
Mastermind Mastermind
Mastermind 15: The Aesthetic Matrix
This course teaches a mechanism-informed approach to aesthetic skin aging by connecting environmental exposures and procedures with cellular stress, inflammation, and repair biology. You’ll review how UVA and UVB contribute to photoaging, how visible/blue light is discussed in pigmentation and...
10 Lessons
17 hrs 24 min
View Course
VIDEO
Cellular Medicine Mondays
Mar 30, 2026
Ep. 081 - The Cellular Impact of UVA vs. UVB Light (Part 1)
Preview Only
Rabbit Holes – Episode 081

The Cellular Impact of UVA vs. UVB Light (Part 1)

In this Rabbit Holes episode, Dr. Seeds explains the mechanistic differences between UVA and UVB light, highlighting how each spectrum uniquely contributes to photoaging, oxidative stress, DNA damage, and skin cancer risk. He also outlines cellular strategies to support antioxidant defenses, mitochondrial function, and DNA repair in response to chronic light exposure.

Want to learn more? Check out Mastermind 15 on Aesthetics!

Preview Only — Become a member for full access
Medivive Mar 27, 2026
SSRP Institute Welcomes Medivive as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [March 27, 2026] — The SSRP Institute is pleased to announce that Medivive has joined its Trusted Partner Network following nomination and internal vetting aligned with SSRP’s mission of advancing science-first, education-driven clinical collaboration. Medivive offers an advanced approach to NAD⁺ therapy designed to support cellular energetics through sterile, clinician-prescribed formulations […]
READ NEWS

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.